Page last updated: 2024-10-23

aztreonam and Cancer of Cervix

aztreonam has been researched along with Cancer of Cervix in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatase, T1
Katabuchi, H1
Watanabe, H1
Umezu, J1
Yakushiji, M1
Kato, T1

Other Studies

1 other study available for aztreonam and Cancer of Cervix

ArticleYear
[Clinical studies on aztreonam in infections in obstetrics and gynecology].
    The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12

    Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral

1985